Shawn Singh - 30 Jun 2022 Form 4 Insider Report for VistaGen Therapeutics, Inc. (VTGN)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Jerrold D. Dotson, Attorney-in-Fact
Issuer symbol
VTGN
Transactions as of
30 Jun 2022
Net transactions value
+$3,740
Form type
4
Filing time
15 Jul 2022, 16:30:29 UTC
Previous filing
16 May 2022
Next filing
18 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VTGN Common Stock Award $3,740 +5,000 +3.4% $0.7480* 153,998 30 Jun 2022 Direct F1
holding VTGN Common Stock 26,234 30 Jun 2022 By The 1997 Singh Family Trust U/R/D 05/29/97
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares purchased under the VistaGen Therapeutics, Inc. 2019 Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3(c)